Great Lakes is pleased to announce a new partnership with OrthoApnea, developer of an innovative mandibular advancement device, NOA, clinically proven to treat obstructive sleep apnea and snoring.

"We are impressed with OrthoApnea's commitment to innovative, high quality, scientific treatment solutions for patients who suffer from sleep apnea and sleep-disordered breathing," said John Ende, Great Lakes president and CEO. "The new NOA is unique in that it was completely developed in a digital environment with the mandibular biomechanics of each patient at the forefront of appliance concept and design."

The custom OrthoApnea NOA features two individual low-profile splints that hold the jaw in a controlled forward position to facilitate breathing and provide a more comfortable experience for the patient. The flexible, controlled advancement allows for lateral jaw movement while preventing joint discomfort. Mandibular advancement is defined by the doctor and performed in a progressive and controlled sequence through a series of lower splints.

OrthoApnea is a global, ISO certified company established in the field of science and biomedical technology. It specializes in developing, producing, and distributing mandibular advancement devices for the treatment of Obstructive Sleep Apnea (OSA).

Great Lakes, an employee-owned company, provides products, laboratory appliances and services, and both in-house and online appliance fabrication training to members of the orthodontic, prosthodontic, restorative, sleep, and general dental professions worldwide. Great Lakes has been a leading innovator in the dental industry since its start as an independent orthodontic lab in 1965. Great Lakes corporate headquarters is located at 200 Cooper Avenue in Tonawanda, New York.